Invicta Diagnostic
Invicta Diagnostic Share Price Chart
Invicta Diagnostic last traded at ₹64.50 (2026-10-13). Over the past month the stock moved -6.5%, three months the stock moved -3.6%. Its closing range over 52 weeks is ₹59.05 – ₹102.75, with the latest close 37.2% below the high.
Closing prices up to 2026-10-13.
About Invicta Diagnostic
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions [1]
Business Overview:[1] IDL is a diagnostic services company operating across the MMR Region under the consumer brand P C Diagnostics, offering integrated radiology and pathology services with a focus on MRI, CT, and PET-CT. The company is supported by a structured hub-and-spoke network.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 15.41 | 2.99 | 19.40 | 0.79 | 0.72 |
| Sep 2025 | 16.95 | 6.76 | 39.88 | 4.08 | 4.32 |
Annual Financials
In the latest year (Mar 2026), Invicta Diagnostic reported sales of ₹32.35 crore (+7.5%) and net profit of ₹4.88 crore (+4.1%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 32.35 | 9.77 | 30.20 | 4.88 | 3.91 |
| Mar 2025 | 30.10 | 9.01 | 29.93 | 4.69 | 5.57 |
| Mar 2024 | 7.99 | 3.40 | 42.55 | 2.69 | 204.56 |
| Mar 2023 | 7.46 | 3.24 | 43.43 | 1.76 | – |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | +7.1% | +276.7% | +7.5% |
| Operating profit growth | +4.9% | +165.0% | +8.4% |
| Net profit growth | +52.8% | +74.3% | +4.1% |
| EPS growth | – | -97.3% | -29.8% |
| OPM % | 42.6% | 29.9% | 30.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Invicta Diagnostic.
Get Free AI Stock Analysis FREE →Latest News
-
Invicta Diagnostic Limited Completes 51% Stake Acquisition in Vinchurkar Diagnostics Private Limited - scanx.trade
-
Invicta Diagnostic Limited Completes 51% Stake Acquisition in Vinchurkar Diagnostics Private Limited - scanx.trade
-
Invicta Diagnostic Limited Completes 51% Stake Acquisition in Vinchurkar Diagnostics Private Limited - scanx.trade
-
Invicta Diagnostic Limited Completes 51% Stake Acquisition in Vinchurkar Diagnostics Private Limited - scanx.trade
Frequently Asked Questions
What is Invicta Diagnostic's current stock price?
Invicta Diagnostic shares were last quoted at ₹64.50 (-2.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Invicta Diagnostic?
Invicta Diagnostic has a price-to-earnings (P/E) ratio of 17.24 and a price-to-book (P/B) ratio of 1.68. The industry P/E is 101.02.
What is the 52-week high and low of Invicta Diagnostic?
The 52-week high of Invicta Diagnostic is ₹105.00 and the 52-week low is ₹58.10.
What is the market cap of Invicta Diagnostic?
The market capitalisation of Invicta Diagnostic is about ₹84.11 crore.
Is Invicta Diagnostic a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Invicta Diagnostic has a 3-year ROE of 20.00%, 3-year profit growth of 41.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Invicta Diagnostic?
Promoters hold about 66.70% of Invicta Diagnostic.
Which sector does Invicta Diagnostic belong to?
Invicta Diagnostic belongs to the Labs & Life Sciences Services sector.
Other Labs & Life Sciences Services stocks
- Syngene International
- Vimta Labs
- Suraksha Diagnostic
- Quest Laboratories
- Gujarat Inject (Kerala)
- Star Imaging & Path Lab
- Modern Diagnostic & Research Centre
- Vineet Laboratories
All Labs & Life Sciences Services stocks · Browse all stocks A–Z